BHAGIRADHA CHEM & INDS L Latest Share Price (BHAGCHEM)
TODAY IN ONE LINE
BHAGCHEM slipped 0.8% on light volume, in line with Nifty's -0.4% move.
With a market cap of ₹3,126.97 Cr., it trades at a P/E of 113.75. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
BHAGIRADHA CHEM & INDS L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 12.3% and Profit up 24.8%
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 2.6%
- ●Expensive ValuationTrading at a high P/E ratio of 206.0x
- ●Low Promoter HoldingPromoters hold only 17.7%
- ●Rising Receivables vs SalesReceivables grew 81.0% outpacing sales growth of 8.1%
Latest BHAGIRADHA CHEM & INDS L News
What changed recently?
Recent events, corporate actions, and announcements.
BHAGIRADHA CHEM & INDS L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for BHAGIRADHA CHEM & INDS L, framed against the sector median so the premium or discount is obvious at a glance.
BHAGIRADHA CHEM & INDS L trades at a P/E of 113.75× and P/B of 4.48×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
BHAGIRADHA CHEM & INDS L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for BHAGIRADHA CHEM & INDS L — derived from the latest tape, not yesterday's close.
BHAGIRADHA CHEM & INDS L last traded at ₹243.85 with an intraday range of ₹242.5–₹251.9 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹243.85| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 268.47 | +24.62 | +10.10% |
| R3 | 259.07 | +15.22 | +6.24% |
| R2 | 255.48 | +11.63 | +4.77% |
| R1 | 249.67 | +5.82 | +2.39% |
| PIVOT | 246.08 | 2.23 | 0.92% |
| CURRENT | 243.85 | — | — |
| S1 | 240.27 | -3.58 | -1.47% |
| S2 | 236.68 | -7.17 | -2.94% |
| S3 | 230.87 | -12.98 | -5.32% |
| S4 | 221.47 | -22.38 | -9.18% |
BHAGCHEM is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹245.1–₹250.2
Trading Inside opening range
BHAGIRADHA CHEM & INDS L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for BHAGIRADHA CHEM & INDS L — consolidated or standalone — with margins, YoY growth and key ratios inline.
BHAGIRADHA CHEM & INDS L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹3,126.97 Cr. and reported EPS of ₹2.12.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 440 | 536 ▲ 21.7% |
| Sales Growth YoY %Derived | 8.05% | 21.67% |
| Other Income | 9 | 2 ▼ 74.5% |
| Total Income | 450 | 538 ▲ 19.7% |
| 278 | 335 ▲ 20.5% | |
| Gross ProfitDerived | 162 | 201 ▲ 23.7% |
| Gross Margin %Derived | 36.86% | 37.46% |
| 125 | 144 ▲ 14.5% | |
| EBITDA (Operating Profit)Derived | 37 | 57 ▲ 54.7% |
| OPM %Derived | 8.39% | 10.66% |
| 21 | 38 ▲ 83.0% | |
| Profit Before Tax (PBT) | 25 | 21 ▼ 16.4% |
| 11 | 3 ▼ 74.2% | |
| Effective Tax %Derived | 45.12% | 13.90% |
| Total Profit for Period | 14 | 18 ▲ 31.1% |
| Net Profit (Owner's PAT)Derived | 14 | 18 ▲ 31.1% |
| Net Profit Margin %Derived | 3.15% | 3.39% |
| PAT Growth YoY %Derived | -23.95% | 31.15% |
| Earnings Per Share (EPS ₹) | 1.07 | 1.40 ▲ 30.8% |
| Diluted Shares Outstanding (Cr) | 13 | 13 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 0 | -0 ▼ 222.5% |
| Total Expenses (incl. D&A & Interest) | 425 | 517 ▲ 21.8% |
| Material Cost % of RevenueDerived | 63.34% | 63.43% |
| Employee Cost % of RevenueDerived | 9.24% | 9.23% |
| Other Cost % of RevenueDerived | 19.23% | 17.57% |
| Interest Coverage (x)Derived | 3.25x | 2.07x |
| Period | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 318 | 436 ▲ 37.0% | 502 ▲ 15.2% | 408 ▼ 18.8% | 440 ▲ 8.1% | 536 ▲ 21.7% | |
| Sales Growth YoY %Derived | — | 37.05% | 15.25% | -18.81% | 8.05% | 21.67% | |
| Other Income | 1 | 1 ▲ 33.1% | 1 ▲ 48.2% | 3 ▲ 112.7% | 9 ▲ 246.4% | 2 ▼ 74.5% | |
| Total Income | 319 | 437 ▲ 37.0% | 503 ▲ 15.3% | 410 ▼ 18.5% | 450 ▲ 9.6% | 538 ▲ 19.7% | |
201 | 277 ▲ 37.8% | 313 ▲ 13.3% | 247 ▼ 21.3% | 278 ▲ 12.8% | 335 ▲ 20.5% | ||
| Gross ProfitDerived | 117 | 159 ▲ 35.8% | 189 ▲ 18.7% | 161 ▼ 14.7% | 162 ▲ 0.8% | 201 ▲ 23.7% | |
| Gross Margin %Derived | 36.82% | 36.49% | 37.58% | 39.50% | 36.86% | 37.46% | |
70 | 91 ▲ 29.3% | 111 ▲ 22.8% | 118 ▲ 6.1% | 125 ▲ 6.2% | 144 ▲ 14.5% | ||
| EBITDA (Operating Profit)Derived | 47 | 68 ▲ 45.6% | 77 ▲ 13.3% | 43 ▼ 44.5% | 37 ▼ 13.9% | 57 ▲ 54.7% | |
| OPM %Derived | 14.75% | 15.67% | 15.40% | 10.53% | 8.39% | 10.66% | |
17 | 18 ▲ 1.9% | 15 ▼ 16.9% | 19 ▲ 26.1% | 21 ▲ 12.4% | 38 ▲ 83.0% | ||
| Profit Before Tax (PBT) | 32 | 51 ▲ 59.6% | 64 ▲ 24.3% | 27 ▼ 57.8% | 25 ▼ 6.2% | 21 ▼ 16.4% | |
9 | 16 ▲ 76.4% | 19 ▲ 19.7% | 9 ▼ 53.3% | 11 ▲ 30.9% | 3 ▼ 74.2% | ||
| Effective Tax %Derived | 27.45% | 30.33% | 29.21% | 32.32% | 45.12% | 13.90% | |
| Total Profit for Period | 23 | 36 ▲ 53.3% | 45 ▲ 26.3% | 18 ▼ 59.6% | 14 ▼ 24.0% | 18 ▲ 31.1% | |
| Net Profit (Owner's PAT)Derived | 23 | 36 ▲ 53.3% | 45 ▲ 26.3% | 18 ▼ 59.6% | 14 ▼ 24.0% | 18 ▲ 31.1% | |
| Net Profit Margin %Derived | 7.34% | 8.21% | 8.99% | 4.47% | 3.15% | 3.39% | |
| PAT Growth YoY %Derived | — | 53.30% | 26.31% | -59.64% | -23.95% | 31.15% | |
| Earnings Per Share (EPS ₹) | 2.27 | 3.48 ▲ 53.3% | 4.34 ▲ 24.7% | 1.75 ▼ 59.7% | 1.07 ▼ 38.9% | 1.40 ▲ 30.8% | |
| Diluted Shares Outstanding (Cr) | 10 | 10 ▲ 0.0% | 10 ▲ 1.4% | 10 ▲ 0.0% | 13 ▲ 24.6% | 13 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | -1 ▼ 696.3% | -1 ▼ 49.9% | 0 ▲ 122.4% | 0 ▼ 57.7% | -0 ▼ 222.5% | |
| Total Expenses (incl. D&A & Interest) | 286 | 385 ▲ 34.5% | 440 ▲ 14.1% | 383 ▼ 12.8% | 425 ▲ 10.7% | 517 ▲ 21.8% | |
| Material Cost % of RevenueDerived | 61.69% | 63.23% | 67.12% | 66.80% | 63.34% | 63.43% | |
| Employee Cost % of RevenueDerived | 6.11% | 5.49% | 5.89% | 8.16% | 9.24% | 9.23% | |
| Other Cost % of RevenueDerived | 15.96% | 15.33% | 16.29% | 20.81% | 19.23% | 17.57% | |
| Interest Coverage (x)Derived | 4.68x | 6.55x | 13.52x | 4.15x | 3.25x | 2.07x |
BHAGIRADHA CHEM & INDS L segment analysis : revenue and profit mix.
Disclosed business segments at BHAGIRADHA CHEM & INDS L with their share of revenue and profit, switchable between consolidated and standalone reporting.
BHAGIRADHA CHEM & INDS L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for BHAGIRADHA CHEM & INDS L.
Our AI distills the core fundamental drivers supporting BHAGIRADHA CHEM & INDS L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
BHAGIRADHA CHEM & INDS L's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
TTM revenue grew 28.9% YoY, demonstrating strong top-line momentum in agrochemicals sector
Low debt-to-equity ratio of 0.0012x provides substantial financial flexibility for growth
Diversified product portfolio spans insecticides, fungicides, herbicides, and intermediates
Global presence across India, Asia, Australia, Europe enhances market reach and diversification
Operating margin of 6.76% reflects reasonable cost management in production operations
Key Risks.
Extreme P/E of 206.04x signals severe overvaluation versus peer median 27.2x
ROE of 3.63% and ROCE of 4.44% far below peer averages, indicating poor capital efficiency
Dividend yield of 0.06% offers minimal shareholder income and returns on investment
Latest quarterly EPS showed 0% growth YoY despite revenue expansion, signaling margin compression
Operating cash flow negative ₹1.11 Cr in FY2025 signals cash burn despite profitability
Flip Conditions.
Valuation risk. a P/E above 148 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
BHAGIRADHA CHEM & INDS L peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — BHAGIRADHA CHEM & INDS L is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
BHAGIRADHA CHEM & INDS L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for BHAGIRADHA CHEM & INDS L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
BHAGIRADHA CHEM & INDS L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for BHAGIRADHA CHEM & INDS L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in BHAGIRADHA CHEM & INDS L stood at 53.3% of traded volume, against a 20-day average of 63.1%.
BHAGIRADHA CHEM & INDS L announcements: results, concalls, ratings, M&A.
Filings BHAGIRADHA CHEM & INDS L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
BHAGIRADHA CHEM & INDS L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 119 documents below.
Credit Rating
Bhagiradha Chemicals & Industries Limited has informed the Exchange about Credit Rating
Analysts/Institutional Investor Meet/Con. Call Updates
Bhagiradha Chemicals & Industries Limited has informed the Exchange about Schedule of meet
Updates
Bhagiradha Chemicals & Industries Limited has informed the Exchange regarding 'Investors Presentation on the Financial Highlights for the quarter…
Copy of Newspaper Publication
Bhagiradha Chemicals & Industries Limited has informed the Exchange about Copy of Newspaper Publication
Outcome of Board Meeting
Bhagiradha Chemicals & Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2026.
Investor decks & rating reports.
BHAGIRADHA CHEM & INDS L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue BHAGIRADHA CHEM & INDS L has declared, sequenced by announce and record date.
BHAGIRADHA CHEM & INDS L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About BHAGIRADHA CHEM & INDS L: business, sector, key facts.
What BHAGIRADHA CHEM & INDS L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
BHAGIRADHA CHEM & INDS L operates in the Pesticides & Agrochemicals industry under the Chemicals sector, listed as NSE: BHAGCHEM, BSE: 531719.
Bhagiradha Chemicals & Industries Limited (BHAGCHEM) is a prominent manufacturer and seller of crop protection chemicals, operating across a significant global footprint encompassing India, Asia, Australia, and Europe. Their core business centers around providing a comprehensive range of agricultural chemicals designed to enhance crop yields and protect against various pests and diseases.
The company's product portfolio is diverse and extensive, encompassing a wide spectrum of insecticides, fungicides, and herbicides. In the insecticide category, BHAGCHEM offers a substantial selection of active ingredients, including but not limited to chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, imidacloprid, pymetrozine, and chlorantraniliprole. These insecticides target a variety of insect pests that commonly threaten agricultural crops.
In addition to insecticides, BHAGCHEM also produces and distributes a variety of fungicides crucial in combating fungal diseases that can significantly impact crop health and yield. Their fungicide offerings include key active ingredients such as azoxystrobin and trifloxystrobin, providing farmers with effective tools to manage fungal infections.
Herbicides form another substantial component of BHAGCHEM's product line. The company supplies a range of herbicides with active ingredients such as triclopyr, cloquintocet-mexyl, clodinafop-propargyl, sulfosulfuron, and pinoxaden, assisting farmers in controlling unwanted weeds that compete with crops for resources.
Beyond its core offerings of finished crop protection chemicals, BHAGCHEM also manufactures specialty intermediates. These intermediates, such as 2,6-dichloroaniline and 2-ethylsulfonylimidazo pyridine-3-sulfonamide, serve as essential building blocks in the synthesis of other agrochemicals. This vertical integration provides BHAGCHEM with greater control over its supply chain and production processes.
Established in 1993 and headquartered in Hyderabad, India, BHAGCHEM has cultivated a significant presence within the global agricultural chemical market, delivering its products to farmers and distributors across multiple continents. The company's broad product portfolio, spanning insecticides, fungicides, herbicides, and specialty intermediates, positions it as a key player in the crop protection industry.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ASTEC LIFESCIENCES (ASTEC) Share PricePeer
- BHARAT RASAYAN (BHARATRAS) Share PricePeer
- DHANUKA AGRITECH (DHANUKA) Share PricePeer
- DHARMAJ CROP GUARD (DHARMAJ) Share PricePeer
- HERANBA INDUSTRIES (HERANBA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about BHAGIRADHA CHEM & INDS L (BHAGCHEM).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of BHAGIRADHA CHEM & INDS L (BHAGCHEM)?
The current share price of BHAGIRADHA CHEM & INDS L (BHAGCHEM) is ₹243.85. Today, the stock has declined by ₹1.90 (0.77%), trading in a range of ₹242.50 to ₹251.90. The stock opened at ₹245.10 with a trading volume of 83,051 shares.
02Is BHAGIRADHA CHEM & INDS L stock a good investment for long-term?
BHAGIRADHA CHEM & INDS L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,126.97 Cr., P/E ratio of 113.75, ROE of 2.6%, and ROCE of 3.64%. The dividend yield stands at 0.06%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of BHAGIRADHA CHEM & INDS L stock?
The 52-week high price of BHAGIRADHA CHEM & INDS L (BHAGCHEM) is ₹316.90, while the 52-week low is ₹170.60. Currently trading at ₹243.85, the stock is 42.94% above its 52-week low and 23.05% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy BHAGIRADHA CHEM & INDS L stock at the current price?
Whether to buy BHAGIRADHA CHEM & INDS L stock at ₹243.85 depends on multiple factors. The stock is currently trading with a P/E ratio of 113.75 and P/B ratio of 4.48. Today's performance shows a loss of 0.77%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of BHAGIRADHA CHEM & INDS L and when is the next dividend?
BHAGIRADHA CHEM & INDS L offers a dividend yield of 0.06%, which means for every ₹100 invested at the current price of ₹243.85, you can expect to receive approximately ₹0.06 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of BHAGIRADHA CHEM & INDS L?
BHAGIRADHA CHEM & INDS L's key financial metrics include: P/E Ratio: 113.75, P/B Ratio: 4.48, ROE: 2.6%, ROCE: 3.64%, Dividend Yield: 0.06%, EPS: ₹2.12, Book Value: ₹53.85, and Debt-to-Equity: 0.33. The company's market cap stands at ₹3,126.97 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is BHAGIRADHA CHEM & INDS L stock performing today in the market?
BHAGIRADHA CHEM & INDS L stock opened at ₹245.10 and is currently trading at ₹243.85, showing a decline of ₹1.90 (0.77%). The intraday high is ₹251.90 and low is ₹242.50. The trading volume stands at 83,051 shares, indicating moderate market participation today.
08What is the P/E ratio of BHAGIRADHA CHEM & INDS L and what does it indicate?
BHAGIRADHA CHEM & INDS L has a Price-to-Earnings (P/E) ratio of 113.75, which means investors are willing to pay 113.75 for every ₹1 of earnings. With an EPS of ₹2.12, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about BHAGIRADHA CHEM & INDS L (BHAGCHEM) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.